Citation Formats

MLA

De Souza, Andre, et al. Commentary: Gsk-3 Inhibition As a Therapeutic Approach Against Sars Cov2: Dual Benefit of Inhibiting Viral Replication While Potentiating the Immune Response. FRONTIERS MEDIA SA, 2020. doi:10.3389/fimmu.2020.595289

APA

De Souza, A., Tavora, F.A., Mahalingam, D., Munster, P.N., Safran, H.P., El-Deiry, W.S., & Carneiro, B.A. (2020). Commentary: GSK-3 Inhibition as a Therapeutic Approach Against SARs CoV2: Dual Benefit of Inhibiting Viral Replication While Potentiating the Immune Response. FRONTIERS MEDIA SA. doi:10.3389/fimmu.2020.595289

Chicago

De Souza, Andre, Fabio A Tavora, Devalingam Mahalingam, Pamela N Munster, Howard P Safran, Wafik S El-Deiry, and Benedito A Carneiro. Commentary: GSK-3 Inhibition As a Therapeutic Approach Against Sars Cov2: Dual Benefit of Inhibiting Viral Replication While Potentiating the Immune Response. FRONTIERS MEDIA SA, 2020. doi:10.3389/fimmu.2020.595289